VistaGen Therapeutics, Inc. (VSTA) at Forefront of Stem Cell Technology for Drug Rescue, Regenerative Medicine, Small Molecule Drugs
VistaGen Therapeutics stands at the forefront today of the rapidly developing world of stem cell technology, with a tight portfolio of IP that cuts hard and fast across multiple, critical applications in the areas of drug rescue and regenerative medicine. The company's Human Clinical Trials in a Test Tube™ platform fuses together proprietary technologies for controlled development/differentiation of human pluripotent (having the potential to differentiate into almost any cell) stem cells into many types of mature, functional adult cells and the utilization thereof. This incredible capacity to produce large quantities of functional adult cells has thus far led to two…